Pueraria Mirifica Extract and Puerarin Enhance Proliferation and Expression of Alkaline Phosphatase and Type I Collagen in Primary Baboon Osteoblasts

Overview

Journal Phytomedicine

Specialty Rehabilitation Medicine

Date 2014 Dec 3

PMID 25442257

Citations 8

Authors

Wacharaporn Tiyasatkulkovit

Suchinda Malaivijitnond

Narattaphol Charoenphandhu

Lorena M Havill

Allen L Ford

John L VandeBerg

Affiliations

Soon will be listed here.

Abstract

Phytoestrogen-rich Pueraria mirifica (PM) tuberous extract is a promising candidate for the development of anti-osteoporosis drugs for postmenopausal women, but its action has never been validated in humans or in non-human primates, which are more closely related to humans than rodents. In vitro study of non-human primate osteoblasts is thus fundamental to prepare for in vivo studies of phytoestrogen effects on primate bone. This study aimed to establish a culture system of baboon primary osteoblasts and to investigate the effects of PM extract and its phytoestrogens on these cells. Primary osteoblasts from adult baboon fibulae exhibited osteoblast characteristics in regard to proliferation, differentiation, mineralization, and estrogen receptor expression. They responded to 17β-estradiol by increased proliferation rate and mRNA levels of alkaline phosphatase (ALP), type I collagen, and osteocalcin. After being exposed for 48 h to 100 μg/ml PM extract, 1000 nM genistein, or 1000 nM puerarin, primary baboon osteoblasts markedly increased the rate of proliferation and mRNA levels of ALP and type I collagen without changes in Runx2, osterix, or osteocalcin expression. PM extract, genistein, and puerarin also decreased the RANKL/OPG ratio, suggesting that they could decrease osteoclast-mediated bone resorption. However, neither PM extract nor its phytoestrogens altered calcium deposition in osteoblast culture. In conclusion, we have established baboon primary osteoblast culture, which is a new tool for bone research and drug discovery. Furthermore, the present results provide substantial support for the potential of PM extract and its phytoestrogens to be developed as therapeutic agents against bone fragility.

Citing Articles

Exosomal miR-590-3p derived from bone marrow mesenchymal stem cells promotes osteoblast differentiation and osteogenesis by targeting TGFBR1.

Luo D, Xie W, He X, Zhou X, Ye P, Wang P In Vitro Cell Dev Biol Anim. 2024; 61(1):46-58.

PMID: 39560913 DOI: 10.1007/s11626-024-00985-1.

Effect of Puerarin on Osteogenic Differentiation in vitro and on New Bone Formation in vivo.

Yang Y, Chen D, Li Y, Zou J, Han R, Li H Drug Des Devel Ther. 2022; 16:2885-2900.

PMID: 36060929 PMC: 9433167. DOI: 10.2147/DDDT.S379794.

Puerarin alleviates osteoporosis in the ovariectomy-induced mice by suppressing osteoclastogenesis via inhibition of TRAF6/ROS-dependent MAPK/NF-κB signaling pathways.

Xiao L, Zhong M, Huang Y, Zhu J, Tang W, Li D Aging (Albany NY). 2020; 12(21):21706-21729.

PMID: 33176281 PMC: 7695364. DOI: 10.18632/aging.103976.

Enzymatic Synthesis of Puerarin Glucosides Using Cyclodextrin Glucanotransferase with Enhanced Antiosteoporosis Activity.

Huang W, He Q, Zhou Z, He H, Jiang R ACS Omega. 2020; 5(21):12251-12258.

PMID: 32548408 PMC: 7271355. DOI: 10.1021/acsomega.0c00950.

Molecular signaling mechanisms behind polyphenol-induced bone anabolism.

Torre E Phytochem Rev. 2017; 16(6):1183-1226.

PMID: 29200988 PMC: 5696504. DOI: 10.1007/s11101-017-9529-x.

References

Komori T . Regulation of osteoblast differentiation by transcription factors. J Cell Biochem. 2006; 99(5):1233-9. DOI: 10.1002/jcb.20958. View

Ma H, Ming L, Ge B, Zhai Y, Song P, Xian C . Icariin is more potent than genistein in promoting osteoblast differentiation and mineralization in vitro. J Cell Biochem. 2011; 112(3):916-23. DOI: 10.1002/jcb.23007. View

Jerome C, Peterson P . Nonhuman primate models in skeletal research. Bone. 2001; 29(1):1-6. DOI: 10.1016/s8756-3282(01)00477-x. View

Cole Z, Dennison E, Cooper C . Osteoporosis epidemiology update. Curr Rheumatol Rep. 2008; 10(2):92-6. DOI: 10.1007/s11926-008-0017-6. View

BLACK A, Lane M . Nonhuman primate models of skeletal and reproductive aging. Gerontology. 2002; 48(2):72-80. DOI: 10.1159/000048930. View

Urasopon N, Hamada Y, Asaoka K, Cherdshewasart W, Malaivijitnond S . Pueraria mirifica, a phytoestrogen-rich herb, prevents bone loss in orchidectomized rats. Maturitas. 2006; 56(3):322-31. DOI: 10.1016/j.maturitas.2006.09.007. View

Havill L, Levine S, Newman D, Mahaney M . Osteopenia and osteoporosis in adult baboons (Papio hamadryas). J Med Primatol. 2008; 37(3):146-53. PMC: 3014087. DOI: 10.1111/j.1600-0684.2007.00270.x. View

Wong K, Li G, Li K, Razmovski-Naumovski V, Chan K . Kudzu root: traditional uses and potential medicinal benefits in diabetes and cardiovascular diseases. J Ethnopharmacol. 2011; 134(3):584-607. DOI: 10.1016/j.jep.2011.02.001. View

Heim M, Frank O, Kampmann G, Sochocky N, Pennimpede T, Fuchs P . The phytoestrogen genistein enhances osteogenesis and represses adipogenic differentiation of human primary bone marrow stromal cells. Endocrinology. 2003; 145(2):848-59. DOI: 10.1210/en.2003-1014. View

10.

Aufdemorte T, Fox W, Miller D, Buffum K, Holt G, Carey K . A non-human primate model for the study of osteoporosis and oral bone loss. Bone. 1993; 14(3):581-6. DOI: 10.1016/8756-3282(93)90197-i. View

11.

Cherdshewasart W, Subtang S, Dahlan W . Major isoflavonoid contents of the phytoestrogen rich-herb Pueraria mirifica in comparison with Pueraria lobata. J Pharm Biomed Anal. 2006; 43(2):428-34. DOI: 10.1016/j.jpba.2006.07.013. View

12.

Neve A, Corrado A, Cantatore F . Osteoblast physiology in normal and pathological conditions. Cell Tissue Res. 2010; 343(2):289-302. DOI: 10.1007/s00441-010-1086-1. View

13.

Malaivijitnond S . Medical applications of phytoestrogens from the Thai herb Pueraria mirifica. Front Med. 2012; 6(1):8-21. DOI: 10.1007/s11684-012-0184-8. View

14.

Zhang C . Transcriptional regulation of bone formation by the osteoblast-specific transcription factor Osx. J Orthop Surg Res. 2010; 5:37. PMC: 2898801. DOI: 10.1186/1749-799X-5-37. View

15.

Urasopon N, Hamada Y, Cherdshewasart W, Malaivijitnond S . Preventive effects of Pueraria mirifica on bone loss in ovariectomized rats. Maturitas. 2008; 59(2):137-48. DOI: 10.1016/j.maturitas.2008.01.001. View

16.

Tiyasatkulkovit W, Charoenphandhu N, Wongdee K, Thongbunchoo J, Krishnamra N, Malaivijitnond S . Upregulation of osteoblastic differentiation marker mRNA expression in osteoblast-like UMR106 cells by puerarin and phytoestrogens from Pueraria mirifica. Phytomedicine. 2012; 19(13):1147-55. DOI: 10.1016/j.phymed.2012.07.010. View

17.

Erben R, Eberle J, Stahr K, Goldberg M . Androgen deficiency induces high turnover osteopenia in aged male rats: a sequential histomorphometric study. J Bone Miner Res. 2000; 15(6):1085-98. DOI: 10.1359/jbmr.2000.15.6.1085. View

18.

Pautke C, Schieker M, Tischer T, Kolk A, Neth P, Mutschler W . Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in comparison to human osteoblasts. Anticancer Res. 2005; 24(6):3743-8. View

19.

OShaughnessy M, Polak J, Afzal F, Hukkanen M, Huang P, MacIntyre I . Nitric oxide mediates 17beta-estradiol-stimulated human and rodent osteoblast proliferation and differentiation. Biochem Biophys Res Commun. 2000; 277(3):604-10. DOI: 10.1006/bbrc.2000.3714. View

20.

Karieb S, Fox S . Zinc modifies the effect of phyto-oestrogens on osteoblast and osteoclast differentiation in vitro. Br J Nutr. 2012; 108(10):1736-45. DOI: 10.1017/S0007114511007355. View